Neolytix and PrescriberPoint announce partnership offering a single managed service for prior authorizations. Service covers medication and procedure authorizations from first coverage check through appeal, with no EHR integration required With PrescriberPoint, the technology moves requests forward quickly, and its specialists take the cases that need a clinical conversation with the payer." - Raj Bhatnagar, Chief Executive Officer of Neolytix CHICAGO, IL, UNITED STATES, September 23, 2026 / EINPresswire.com / - Neolytix, a healthcare management services organization, and PrescriberPoint, an AI point-of-care platform, today announced a partnership to give mid-market physician practices a single managed service for prior authorization, covering both medication and procedure requests from first coverage check through appeal. Under the partnership, PrescriberPoint's Prior Authorization platform will automate prescription authorizations that run through the pharmacy benefit plan. Neolytix clinical specialists handle medical-benefit authorizations for imaging, procedures and physician-administered drugs, and work the appeals on both. Physician practices deal with one team at Neolytix across the entire cycle, with no handoff between vendors when a case needs a person. Medicare Advantage insurers denied 4.1 million prior authorization requests for medical care in 2024, according to KFF. Nearly nine in ten of those denials were never appealed, even though more than four in five appeals succeeded. Ultimately, whether a patient gets treatment often comes down to whether the practice has the bandwidth and resources to initiate an appeal. The burden falls on practices and patients alike. Physicians and their staff spend 13 hours a week on prior authorization, 40 percent of physicians have staff who work on nothing else, and more than one in four say it has led to a serious adverse event for a patient, according to the American Medical Association. "When a denial gets worked, the practice usually wins. The problem is that most never get worked, because nobody has the time," said Raj Bhatnagar, Chief Executive Officer of Neolytix. "We see it across the more than 300 organizations we support. With PrescriberPoint, the technology moves requests forward quickly, and our specialists take the cases that need a clinical conversation with the payer. That's how we think about AI at Neolytix: it makes skilled people more effective." "Most of the technology built for prior authorization was priced and designed for larger health systems, while smaller specialty practices carry the same burdens with none of the same resources," said Dan Cornwell, Chief Executive Officer of PrescriberPoint. "Our goal is simple: get patients started on therapy faster with resolved denials, so that patients get their medications and the administrative load on physician practices is reduced." Patients receive text updates on authorization status and pharmacy routing from the moment a prescription is written, along with enrollment in copay assistance programs, with no app or portal login required. The service will be available to Neolytix practice clients beginning in November, starting with rheumatology, gastroenterology, pain management and weight management practices. About Neolytix Neolytix empowers healthcare organizations with AI-driven solutions that streamline operations, enhance care quality, and boost productivity. The company delivers tailored support across revenue cycle and administrative operations, reducing inefficiencies and freeing providers to focus on patient care. With 14+ years of healthcare expertise, Neolytix has helped 300+ healthcare organizations optimize revenue cycles, improve workflows, and navigate financial pressures and regulatory complexity. By turning operational hurdles into competitive advantages, Neolytix enables healthcare organizations to achieve better outcomes for patients and providers alike. For more information, visit www.neolytix.com. About PrescriberPoint PrescriberPoint is an AI-powered point-of-care platform that supports clinicians at every step of the prescribing journey - from researching FDA-approved drug and clinical information, to understanding coverage and out-of-pocket costs, to submitting prior authorizations and enrolling patients in the right savings programs. Prescriber.AI, the company's AI Agent platform, automates many of these time-consuming tasks by answering drug questions on demand, guiding clinicians through coverage and savings decisions, and managing prior authorization submissions. In 2025, PrescriberPoint reached more than 5 million healthcare professionals, including prescribers and staff, establishing it as one of the largest active HCP networks in digital health. That scale gives life sciences companies a direct line into the prescribing moment - reducing access barriers and driving measurable therapy adoption. Learn more at Media Contacts Neolytix - George Goodno, [email protected], (312) 757-1599 PrescriberPoint - Ivy Cohen, [email protected], (212) 399-0026 George Goodno Neolytix +1 312-757-1599 [email protected] Visit Asia Pacific Herald on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Asia Pacific Herald do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

PrescriberPoint appoints dr. Steven Strongwater as Chief Medical Officer. June 22, 2026 Steven Strongwater, M.D. PrescriberPoint has named healthcare executive and physician leader Steven Strongwater, M.D., as Chief Medical Officer, creating a new leadership position as the company expands its portfolio of artificial intelligence-powered solutions designed to streamline prescribing and medication access workflows. The appointment comes as healthcare organizations increasingly look to automation and AI technologies to reduce administrative burdens that contribute to clinician burnout and delays in patient care. PrescriberPoint, which operates an AI-enabled point-of-care platform, has focused on simplifying tasks such as medication research, coverage verification, prior authorizations, and patient access programs. In his new role, Strongwater will oversee the company's clinical strategy and help strengthen relationships with healthcare organizations, ensuring that PrescriberPoint's technology development remains aligned with provider and patient needs. "Steve brings a unique combination of clinical expertise, healthcare leadership, and a deep understanding of the challenges facing today's providers," said Dan Cornwell, Chief Executive Officer of PrescriberPoint. "As we continue building AI-powered solutions, he will help ensure our innovations stay grounded in real clinical needs and deliver meaningful value for patients and providers." Strongwater joins the company with more than 20 years of leadership experience across integrated health systems and academic medical centers. Most recently, he served as President and Chief Executive Officer of Atrius Health, where he led the organization through its acquisition by Optum, part of UnitedHealth Group, and oversaw the establishment of the Atrius Health Equity Foundation. Throughout his career, Strongwater has held executive leadership roles at UMass Medical Center, the University of Connecticut Health Center, Geisinger Health System, and Stony Brook University Hospital. His work has centered on population health management, quality improvement, patient safety, and physician well-being, with a particular focus on reducing operational friction that can impede care delivery. The hire follows a period of growth for PrescriberPoint as healthcare providers increasingly seek tools that can help manage mounting administrative requirements. In April, the company reported validation results for its AI-powered Prior Authorization Agent, which achieved a 94.5% clinician acceptance rate while automating portions of the prior authorization process, one of the most time-intensive administrative functions in healthcare. "Healthcare professionals are spending too much time navigating administrative complexity and not enough time caring for patients," Strongwater said. "PrescriberPoint's mission aligns closely with the work I've focused on throughout my career, and I'm excited to help advance solutions that use AI responsibly to reduce friction and improve access to care." The appointment reflects a broader shift across healthcare technology as providers and health systems evaluate how artificial intelligence can improve operational efficiency without disrupting clinical workflows. Companies developing AI solutions for healthcare are increasingly emphasizing clinical oversight and physician leadership to support adoption and ensure that technology addresses real-world challenges faced by care teams. Strongwater currently serves on the Massachusetts Health Quality Partnership Primary Care Advisory Committee and holds multiple board positions with organizations focused on healthcare innovation and delivery transformation. He was recognized by Modern Healthcare as one of its Top 50 Healthcare Executives in 2020. PrescriberPoint's platform supports clinicians throughout the prescribing process, providing access to FDA-approved drug information, coverage details, patient cost information, prior authorization tools, and savings program enrollment. Through its Prescriber.AI platform, the company automates many of these workflows using AI-driven agents designed to assist providers at the point of care. The company said it reached more than 5 million healthcare professionals, including prescribers and support staff, in 2025, making it one of the largest active healthcare professional networks in digital health. As adoption of AI accelerates across healthcare, PrescriberPoint is positioning itself at the intersection of clinical decision support, medication access, and administrative automation.

PrescriberPoint, an AI point-of-care platform, has appointed Steven Strongwater, MD, as chief medical officer. Dr Strongwater will guide clinical strategy and foster healthcare relationships as the company expands its AI-enabled solutions for prescribing and medication access workflows. Dr Strongwater brings over two decades of health-system leadership, most recently serving as president and CEO of Atrius Health, where he oversaw its acquisition by UnitedHealth Group's Optum. He has held executive roles at UMass Medical Center, Geisinger Health System and other major health systems, and was named one of Modern Healthcare's Top 50 Healthcare Executives in 2020. In April, PrescriberPoint announced its AI-powered Prior Authorization Agent achieved a 94.5% clinician acceptance rate. The platform reached over 5 million healthcare professionals in 2025.